No abstract available
MeSH terms
-
Biomarkers / blood
-
Clinical Trials, Phase III as Topic* / methods
-
Endpoint Determination* / methods
-
Humans
-
Male
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / blood*
-
Prostatic Neoplasms / diagnosis
Substances
-
Biomarkers
-
Prostate-Specific Antigen